FDA issued a Warning Letter to bioMerieux, Inc. on 8/23/2012 for a previous inspection.
483 bioMerieux Jan 2016

483 bioMerieux Jan 2016

Dawn Braswell FDA, Sayeeda Hdabe FDA, Samuel Murray FDA, Miaja Umaedi FDA$595.00 - Available Now

FDA investigators audited the bioMerieux - Durham, NC, United States facility and issued inspectional observations (via FDA 483) on 05 Jan 2016.

Product details

  • Category: Medical Devices & Rad Health
  • Inspection end: 05 Jan 2016
  • Location: Durham, United States
  • FEI: 3002769706
Add To Cart